Advertisement

Pathophysiologie der primären Hypertriglyceridämien

  • F. Sandhofer
  • S. Sailer
  • H. Braunsteiner
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde Neue Folge / Advances in Internal Medicine and Pediatrics book series (KINDERHEILK. NF, volume 31)

Zusammenfassung

Triglyceride (TG) können durch die Nahrung aufgenommen oder im Körper selbst von verschiedenen Organen gebildet werden. Sie werden im Fettgewebe gespeichert oder in anderen Organen zur Energiegewinnung verbrannt. Diese Vorgänge setzen den Transport der TG im Blut voraus. TG sind aber wasserunlöslich; trotzdem müssen beträchtliche Mengen im Plasma, das als wäßrige Phase zu betrachten ist, transportiert werden. Um dies zu ermöglichen, werden die TG mit anderen Lipiden (freies und verestertes Cholesterin, Phospholipide) und mit spezifischen Proteinen verbunden, wodurch makromolekulare Komplexe geformt werden, die sog. Lipoproteide (LP). Schon 1901 wies Nerking auf das Vorhandensein von Fett-Eiweiß-Komplexen im Serum hin.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abrams, M. E., Jarrett, R. J., Keen, H., Boyns, D. R., Crossley, J. N.: Oral glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response. Brit. med. J. 1969I, 599–602.Google Scholar
  2. Adlersberg, D., Wang, C.-I.: Syndrome of idiopathic hyperlipemia, mild diabetes mellitus, and severe vascular damage. Diabetes 4, 210–218 (1955).PubMedGoogle Scholar
  3. Ahrens, E. H., Jr.: Essential hyperlipemia. In: Fat Metabolism. Baltimore: Johns Hopkins Press 1954.Google Scholar
  4. Ahrens, E. H., Jr., Hirsch, J., Insull, W., Jr., Tsaltas, T. T., Blomstrand, R., Peterson, M. L.: The influence of dietary fats on serum lipid levels in man. Lancet 1957aI, 943–953.Google Scholar
  5. Ahrens, E. H., Jr., Hirsch, J., Insull, W., Jr., Tsaltas, T. T., Blomstrand, R., Peterson, M. L.Dietary control of serum lipids in relation to atherosclerosis. J. Amer. med. Ass. 164, 1905–1911 (1957b).Google Scholar
  6. Ahrens, E. H., Jr., Hirsch, J., Oette, K., Farquhar, J. W., Stein, Y.: Carbohydrate-induced and fat-induced lipemia. Trans. Ass. Amer. Phycns. 74, 134–146 (1961).Google Scholar
  7. Albrink, M. J., Davidson, P. C.: Impaired glucose tolerance in patients with hypertriglyceridemia. J. Lab. clin. Med. 67, 573–584 (1966).Google Scholar
  8. Ahrens, E. H., Jr., Man, E. B.: Effect of carbohydrate ingestion on postprandial lipemia. Amer. J. dig. Dis. 2, 649–653 (1957).Google Scholar
  9. Ahrens, E. H., Jr., Man, E. B.: Serum triglycerides in coronary artery disease. Arch. int. Med. 103, 4–8 (1959).Google Scholar
  10. Albrink, M. J., Fitzgerald, J. R., Man, E. B.: Reduction of alimentary lipemia by glucose. Metabolism 7, 162–171 (1958).PubMedGoogle Scholar
  11. Anderson, J. T., Grande, F., Matsumoto, Y., Keys, A.: Glucose, sucrose and lactose in the diet and blood lipids in man. J. Nutrit. 79, 349–359 (1963).PubMedGoogle Scholar
  12. Anfinsen, C. B., Boyle, E., Brown, R. K.: The role of heparin in lipoprotein metabolism. Science 115, 583–586 (1952).PubMedGoogle Scholar
  13. Angervall, G., Björntorp, P., Hood, B.: Studies on the clearing phenomenon in essential hyperlipemia. Acta med. scand. 172, 5–14 (1962).PubMedGoogle Scholar
  14. Antar, M. A., Ohlson, M. A.: Effect of simple and complex carbohydrates upon total lipids, nonphospholipids, and different fractions of phospholipids of serum in young men and women. J. Nutr. 85, 329–337 (1965).PubMedGoogle Scholar
  15. Antonis, A., Bersohn, I.: The influence of diet on serum triglycerides in South African white and Bantu prisoners. Lancet 1961 I, 3–9Google Scholar
  16. Armstrong, D. T., Steele, R., Bishop, J. S., de Bodo, R. C.: Regulation of plasma free fatty acid turnover. Amer. J. Physiol. 201, 9–15 (1961).PubMedGoogle Scholar
  17. Ashworth, C. T., Diluzio, N. R., Riggi, S. J.: A morphologic study of the effect of reticuloendothelial stimulation upon hepatic removal of minute particles from the blood of rats. Exp. Molecular Path. Suppl. 1, 83–103 (1963).Google Scholar
  18. Bagdade, J. D., Porte, D., Jr., Bierman, E. L.: Diabetic lipemia: a form of acquired fat-induced lipemia. New Engl. J. Med. 276, 427–433 (1967).PubMedGoogle Scholar
  19. Bagdade, J. D., Porte, D., Jr., Bierman, E. L.: Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes 17, 127–132 (1968).PubMedGoogle Scholar
  20. Bassen, F. A., Kornzweig, A. L.: Malformation of erythrocytes in a case of atypical retinitis pigmentosa. Blood 5, 381–387 (1950).PubMedGoogle Scholar
  21. Belfrage, P., Borgström, B., Olivecrona, T.: The tissue distribution of radioactivity following the injection of varying levels of fatty acid labeled chylomicrons in the rat. Acta physiol. scand. 58, 111–123 (1963).PubMedGoogle Scholar
  22. Bergquist, L. M., Carroll, V. P., Jr., Searcy, R. L.: Evaluation of a specific antiserum for serum- β-lipoprotein estimations. Lancet 1961I, 537–538.Google Scholar
  23. Berkowitz, D.: Blood lipid and uric acid interrelationships. J. Amer. Med. Ass. 190, 856–858 (1964).Google Scholar
  24. Berman, M.: Compartmental analysis in kinetics. In: Computers in Biochemical Research, Stacy, R.W., Waxman, B.D. (Hersg.), New York: Academic Press Inc. Vol. 2 (1965).Google Scholar
  25. Berman, M., Shahn, E., Weiss, M. F.: The routine fitting of data to models: A mathematical formalism for digital computers. Biophys. J. 2, 275–288 (1962a).PubMedGoogle Scholar
  26. Berman, M., Weiss, M. F., Shahn, E.: Some formal approaches to the analysis of kinetic data in terms of linear compartmental systems. Biophys. J. 2, 289–299 (1962b).PubMedGoogle Scholar
  27. Beveridge, J. M. R., Jagannathan, S. N., Connell, W. F.: The effect of the type and amount of dietary fat on the level of plasma triglycerides in human subjects in the post-absorptive state. Canad. J. Biochem. 42, 999–1003 (1964).Google Scholar
  28. Bezman, A., Felts, J. M., Havel, R. J.: Relation between incorporation of triglyceride fatty acids and heparin-released lipoprotein lipase from adipose tissue slices. J. Lipid Res. 3, 427–431 (1962).Google Scholar
  29. Bialkin, G., Zucker, S., Sklarin, B. S., Hirschhorn, K., Davidson, M.: A genetic and metabolic study of a family with hyperlipemia. Pediatrics 29, 566–578 (1962).PubMedGoogle Scholar
  30. Bierman, E. L.: Particulate lipid components in plasma. In: Handbook of Physiology, Section 5: Adipose Tissue, A. E. Renold and G. F. Cahill, Jr. (Hrsg.) 509–518 (1965), Baltimore, MD.: Waverly Press, Inc.Google Scholar
  31. Bierman, E. L., Hamlin, J. T. III: A preparation of C14-labeled triglyceride in plasma as a tracer for plasma particulate fat. Proc. Soc. exp. Biol. (N. Y.) 109, 747–750 (1962).Google Scholar
  32. Bierman, E. L., Porte, D., Jr.: Carbohydrate intolerance and lipemia. Ann. int. Med. 68, 926–933 (1968).PubMedGoogle Scholar
  33. Bierman, E. L., Strandness, D. E. Jr.: The mechanism of formation of secondary fat particles from lymph chylomicrons. J. clin. Invest. 44, 1028 (1965).Google Scholar
  34. Bierman, E. L., Amaral, J. A. P., Belknap, B. H.: Hyperlipemia and diabetes mellitus. Diabetes 15, 675–679 (1966 b).PubMedGoogle Scholar
  35. Bierman, E. L., Gordis, E., Hamlin, J. T. III.: Heterogeneity of fat particles in plasma during alimentary lipemia. J. clin. Invest. 41, 2254–2260 (1962).PubMedGoogle Scholar
  36. Bierman, E. L., Hayes, T. L., Hawkins, J. N., Ewing, A. M., Lindgren, F. T.: Particle-size distribution of very low density plasma lipoproteins during fat absorption in man. J. Lipid Res. 7, 65–72 (1966 a).PubMedGoogle Scholar
  37. Bierman, E. L., Porte, D., Jr., O’Hara, D. D., Schwartz, M., Wood, F. C., Jr.: Characterization of fat particles in plasma of hyperlipemic subjects maintained on fat-free high-carbohydrate diets. J. clin. Invest. 44, 261–270 (1965).PubMedGoogle Scholar
  38. Björklund, R., Katz, S.: Molecular weights and dimensions of some human serum lipoproteins. J. Amer. Chem. Soc. 78, 2122–2126 (1956).Google Scholar
  39. Blomstrand, R., Thorn, N. A., Ahrens, E. H., Jr.: The absorption of fats, studied in a patient with chyluria. I. Clinical investigation. Amer. J. Med. 24, 958–966 (1958).PubMedGoogle Scholar
  40. Bierman, E. L., Dahlbäck, O.: The fatty acid composition of human thoracic duct lymph lipids. J. clin. Invest. 39, 1185–1191 (1960).Google Scholar
  41. Bloom, B., Chaikoff, I. L., Reinhardt, W. O.: Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths. Amer. J. Physiol. 166, 451–455 (1951).PubMedGoogle Scholar
  42. Bloom, B., Entenman, C., Dauben, W. G.: The quantitative significance of the lymphatic pathway in transport of absorbed fatty acids. J. biol. Chem. 184, 1–8 (1950).PubMedGoogle Scholar
  43. Boberg, J., Carlson, L. A.: Determination of heparin-induced lipoprotein lipase activity in human plasma. Clin. chim. Acta 10, 420–427 (1964).PubMedGoogle Scholar
  44. Boberg, J., Hallberg, D.: Changes in endogenous plasma triglycerides during elimination of exogenous triglycerides from the blood in man. J. Atheroscler. Res. 8, 351–356 (1968).PubMedGoogle Scholar
  45. Boberg, J., Carlson, L. A., Freyschuss, U.: Studies on the total and splanchnic turnover of plasma free fatty acids and plasma triglycerides in man by means of isotopic and chemical methods. Persönliche Mitteilung (1969b).Google Scholar
  46. Boberg, J., Carlson, L. A., Hallberg, D.: Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man. J. Atherscler. Res. 9, 159–169 (1969a).Google Scholar
  47. Boberg, J., Carlson, L. A., Normell, L.: Production of lipolytic activity by the isolated perfused dog liver in response to heparin. Biochem. J. 92, 43 P (1964).Google Scholar
  48. Bolzano, K., Sailer, S., Sandhofer, F., Braunsteiner, H.: Über das Verhalten der endogenen Lipoproteidlipase-Aktivität im Plasma während einer intravenösen Fettinfusion bei Normalpersonen und Patienten mit Hypertriglyceridämie. Klin. Wschr. 45, 1104–1106 (1967).PubMedGoogle Scholar
  49. Bolzano, K., Sailer, S., Sandhofer, F., Braunsteiner, H.: Die Beeinflussung der endogenen und der Post-Heparin-Lipoproteidlipase-Aktivität im Plasma durch intravenöse Glukosebelastung bei Normalpersonen, Patienten mit primärer endogener Hypertriglyceridämie und Personen mit diabetischer Stoff-wechsellage. Klin. Wschr. (1971), im Druck.Google Scholar
  50. Borgström, B.: Transport form of 14C-decanoic acid in portal and inferior vena cava blood during absorption in the rat. Acta physiol. scand. 34, 71–74 (1955).PubMedGoogle Scholar
  51. Borgström, B., Jordan, P.: Metabolism of chylomicron glyceride as studied by C14-glycerol-C14-palmitic acid labeled chylomicrons. Acta Soc. Med. Upsalien. 64, 185–193 (1959).Google Scholar
  52. Borgström, B., Olivecrona, T.: The metabolism of palmitic acid-1-C14 in functionally hepatectomized rats. J. Lipid. Res. 2, 263–267 (1961).Google Scholar
  53. Bragdon, J. H.: On the composition of chyle chylomicrons. J. Lab. clin. Med. 52, 564–570 (1958).PubMedGoogle Scholar
  54. Borgström, B., Gordon, R. S., Jr.: Tissue distribution of C-14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. J. clin. Invest. 37, 574–578 (1958).Google Scholar
  55. Borgström, B., Havel, R. J.: In vivo effect of anti-heparin agents on serum lipids and lipoproteins. Amer. J. Physiol. 177, 128–133 (1954).Google Scholar
  56. Borgström, B., Havel, R. J., Boyle, E.: Human serum lipoproteins. I. Chemical composition of four fractions. J. Lab. clin. Med. 48, 36–42 (1956).Google Scholar
  57. Borgström, B., Havel, R. J., Gordon, R. S., Jr.: Effects of carbohydrate feeding on serum lipids and lipoproteins in the rat. Amer. J. Physiol. 189, 63–67 (1957).Google Scholar
  58. Braunsteiner, H., Berger, H., Sailer, S., Sandhofer, F.: Untersuchungen bei einem Fall von fettinduzierter (exogener) Hypertriglyceridämie. Schwei. med. Wschr. 98, 458–461 (1968 a).Google Scholar
  59. Braunsteiner, H., di Pauli, R., Sailer, S., Sandhofer, F.: Hyperlipämie und latenter Diabetes mellitus. Klin. Wschr. 43, 715–717 (1965 b).PubMedGoogle Scholar
  60. Braunsteiner, H., Dittrich, P. v., Sailer, S., Sandhofer, F.: nicht veröffentlicht (1968c).Google Scholar
  61. Braunsteiner, H., Herbst, M., Rhomberg, H., Sailer, S., Sandhofer, F.: Familienuntersuchungen bei primärer kohlenhydratinduzierter Hypertriglyceridämie. Schweiz. med. Wschr. 99, 286–291 (1969 b).PubMedGoogle Scholar
  62. Braunsteiner, H., Herbst, M., Sailer, S., Sandhofer, F.: Familienuntersuchungen bei essentieller „kohlenhydratinduzierter“Hyperlipämie. Dtsch. med. Wschr. 92, 646–652 (1967 a).PubMedGoogle Scholar
  63. Braunsteiner, H., Herbst, M., Sailer, S., Sandhofer, F.: Essentielle Hyperlipämie und akute Pankreatitis. Schweiz, med. Wschr. 97, 698–702 (1967 b).Google Scholar
  64. Braunsteiner, H., Herbst, M., Sailer, S., Sandhofer, F.: Diabetes mellitus bei primärer Hypertriglyceridämie mit Kontraindikation zur Insulinbehandlung. Wien. klin. Wschr. 80, 415–417 (1968b).PubMedGoogle Scholar
  65. Braunsteiner, H., Sailer, S., Sandhofer, F., di Pauli, R., Gabl, F., Jung, A.: Lipidwerte bei gesunden Personen und Patienten mit Myocardinfarkt. Statistische Auswertung mit Hilfe einer elektronischen Rechenanlage. Wien. klin. Wschr. 77, 859–862 (1965 a).PubMedGoogle Scholar
  66. Braunsteiner, H., Sandhofer, F., Sailer, S.: Hyperlipämie und akute Pankreatitis. T. Gastro-ent. 12, 32–37 (1969a).Google Scholar
  67. Braunsteiner, H., Sandhofer, F., Sailer, S.: Primäre Hypertriglyceridämie und Atherosklerose. Wien. klin. Wschr. 81, 401–403 (1969 c).PubMedGoogle Scholar
  68. Brech, W. J., Gordon, E. S.: Incorporation of radioactivity from glucose into plasma lipids in hyperlipemia. Sixth Congress of the International Diabetes Federation, Stockholm, 1967. Excerpta med. ICS 140, 150 (1967).Google Scholar
  69. Bressler, R., Wakil, S. J.: Studies on the mechanism of fatty acid synthesis. IX. The conversion of malonyl coenzyme A to long chain fatty acids. J. biol. Chem. 236, 1643–1651 (1961).Google Scholar
  70. Brown, D. F.: Triglyceride metabolism in the alloxan-diabetic rat. Diabetes 16, 90–95 (1967).PubMedGoogle Scholar
  71. Brown, D. F., Olivecrona, T.: The effect of glucose availability and utilization on chylomicron metabolism in the rat. Acta physiol. scand. 66, 9–18 (1966).PubMedGoogle Scholar
  72. Brown, W. D.: Reversible effects of anticoagulants and protamine on alimentary Hpaemia. Quart. J. exp. Physiol. 37, 75–84 (1952).PubMedGoogle Scholar
  73. Brunner, W.: Beitrag zur pankreatogenen Lipämie. Klin. Wschr. 14, 1853–1855 (1935).Google Scholar
  74. Bublitz, C., Kennedy, E. P.: Synthesis of phosphatides in isolated mitochondria. III. The enzymatic phosphorylation of glycerol. J. biol. Chem. 211, 951–961 (1954).Google Scholar
  75. Bürger, M., Grütz, O.: Über hepatosplenomegale Lipoidose mit Xanthomatosen Veränderungen in Haut und Schleimhaut. Arch. Derm. Syph. (Berl.) 166, 542–575 (1932).Google Scholar
  76. Burstein, M., Samaille, J.: Sur une nouvelle méthode de préparation d’un immunsérum anti-β-lipoprotéines specifiques. Rev. franç. Étud. clin. biol. 3, 624–626 (1958).PubMedGoogle Scholar
  77. Carlson, L. A.: Chromatographic separation of serum lipoproteins on glass powder columns. Description of the method and some applications. Clin. chim. Acta 5, 528–538 (1960a).PubMedGoogle Scholar
  78. Carlson, L. A.: Serum lipids in man with myocardial infarction. Acta med. scand. 167, 399–413 (1960 b).PubMedGoogle Scholar
  79. Carlson, L. A.: Studies on the incorporation of injected palmitic acid-1-C14 into liver and plasma lipids in man. Acta Soc. Med. upsalien. 65, 85–90 (1960 c).Google Scholar
  80. Carlson, L. A.: Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro. Acta med. scand. 173, 719–722 (1963).PubMedGoogle Scholar
  81. Carlson, L. A., Ekelund, L.-G.: Splanchnic production and uptake of endogenous triglycerides in the fasting state in men. J. clin. Invest. 42, 714–720 (1963).PubMedGoogle Scholar
  82. Carlson, L. A., Nye, E. R.: Acute effects of nicotinic acid in the rat. I. Plasma and liver lipids and blood glucose. Acta med. scand. 179, 453–461 (1966).PubMedGoogle Scholar
  83. Carlson, L. A., Olhagen, B.: The electrophoretic mobility of chylomicrons in a case of essential hyperlipemia. Scand. J. clin. Lab. Invest. 6, 70–73 (1954).PubMedGoogle Scholar
  84. Carlson, L. A., Orö, L.: The effect of nicotinic acid on the plasma free fatty acids. Demonstration of a metabolic type of sympathicolysis. Acta med. scand. 172, 641–645 (1962).PubMedGoogle Scholar
  85. Carlson, L. A., Östman, J.: Inhibition of the mobilization of free fatty acids from adipose tissue in diabetes. I. Effects of nicotinic acid on the alloxan-diabetic state in rats. Acta med. scand. 177, 631–637 (1965).PubMedGoogle Scholar
  86. Carlson, L. A., Havel, R. J., Ekelund, L.-G., Holmgren, A.: Effect of nicotinic acid on the turnover rate and oxidation of the free fatty acids of plasma in man during exercise. Metabolism 12, 837–845 (1963).PubMedGoogle Scholar
  87. Carlson, L. A., Liljedahl, S.-O., Wirsen, C.: Blood and tissue changes in the dog during and after excessive free fatty acid mobilization. Acta med. scand. 178, 81–102 (1965).PubMedGoogle Scholar
  88. Cherkes, A., Gordon, R. S., Jr.: The liberation of lipoprotein lipase by heparin from adipose tissue incubated in vitro. J. Lipid Res. 1, 97–101 (1959).Google Scholar
  89. Christensen, S., Dollerup, E., Jensen, S. E.: Idiopathic hyperlipaemia, latent diabetes mellitus, and severe neuropathy. Acta med. scand. 161, 57–68 (1958).PubMedGoogle Scholar
  90. Christophe, J., Mayer, J.: Influence of diet on utilization of glucose and incorporation of acetate-1-C14 into liver fatty acids and cholesterol in rats. Amer. J. Physiol. 197, 55–59 (1959).PubMedGoogle Scholar
  91. Clark, B., Hübscher, G.: Biosynthesis of glycerides in the mucosa of the small intestine. Nature (Lond.) 185, 35–37 (1960).Google Scholar
  92. Clark, B., Hübscher, G.: Glycerokinase in mucosa of the small intestine of the cat. Nature (Lond.) 195, 599–600 (1962).Google Scholar
  93. Cleland, W., Iacono, J. M.: Role of lipoprotein lipase in intravascular clearing of fat in human subjects. Fed. Proc. 16, 383 (1957).Google Scholar
  94. Cohn, E. J., Strong, L. E., Hughes, W. L., Jr., Mulford, D. J., Ashworth, J. N., Melin, M., Taylor, H. L.: Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Amer. chem. Soc. 68, 459–475 (1946).Google Scholar
  95. Condon, R. E., Tobias, H., Datta, D. V.: The liver and postheparin plasma lipolytic activity in dog and man. J. clin. Invest. 44, 860–869 (1965).PubMedGoogle Scholar
  96. Cornwell, D. G., Kruger, F. A.: Molecular complexes in the isolation and characterization of plasma lipoproteins. J. Lipid Res. 2, 110–134 (1961).PubMedGoogle Scholar
  97. Csorba, T. R., Matsuda, I., Kalant, N.: Effects of insulin and diabetes on flux rates of plasma glucose and free fatty acids. Metabolism 15, 262–270 (1966).PubMedGoogle Scholar
  98. Davidson, P. C., Albrink, M. J.: Insulin resistance in hyperglyceridemia. Metabolism 14, 1059–1070 (1965 a).PubMedGoogle Scholar
  99. Davidson, P., Albrink, M.: The relation of insulin responsiveness to plasma triglyceride levels. Clin. Res. 13, 71 (1965 b).Google Scholar
  100. Davidson, P., Albrink, M.: Abnormal plasma insulin response with high plasma triglycerides independent of clinical diabetes or obesity. J. clin. Invest. 45, 1000 (1966).Google Scholar
  101. Dawson, A. M., Isselbacher, K. J.: The esterification of palmitate-1-C14 by homogenates of intestinal mucosa. J. clin. Invest. 39, 150–160 (1960).PubMedGoogle Scholar
  102. Dawson, A. M., Isselbacher, K. J.: Bell, V. M.: Studies on lipid metabolism in the small intestine with observations on the role of bile salts. J. clin. Invest. 39, 730–740 (1960).PubMedGoogle Scholar
  103. Denborough, M. A., Paterson, B.: Clearing factor, fibrinolysis and blood lipids in diabetes mellitus. Clin. Sci. 23, 485–488 (1962).PubMedGoogle Scholar
  104. Dole, V. P.: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest. 35, 150–154 (1956).PubMedGoogle Scholar
  105. Dole, V. P., Rizack, M. A.: On the turnover of long-chain fatty acids in plasma. J. Lipid Res. 2, 90–91 (1961).Google Scholar
  106. Eagle, G. R., Robinson, D. S.: The ability of actinomycin D to increase clearing-factor lipase activity of rat adipose tissue. Biochem. J. 93, 10C–11C (1964).PubMedGoogle Scholar
  107. Eaton, R. P., Berman, M., Steinberg, D.: Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J. clin. Invest. 48, 1560–1579 (1969).PubMedGoogle Scholar
  108. Edgren, B.: The removal of artificial fat emulsions from the blood stream of dogs. Acta physiol. scand. 48, 390–401 (1960).PubMedGoogle Scholar
  109. Edgren, B., Zilversmit, D. B.: Uptake of C14–1-palmitic acid-P32-phospholipid labeled chylomicrons by perfused liver and liver slices. Proc. Soc. exp. Biol. (N. Y.) 119, 64–71 (1965).Google Scholar
  110. Engelberg, H.: Human endogenous lipemia clearing factor (active factor). Amer. J. Physiol. 181, 309–312 (1955).PubMedGoogle Scholar
  111. Ewing, A. M., Freeman, N. K., Lindgren, F. T.: The analysis of human serum lipoprotein distributions. In: Advances in Lipid Research. R. Paoletti and D. Kritchevsky (Hrsg.). Vol. 3, pp. 25–31. New York-London: Academic Press 1965.Google Scholar
  112. Farquhar, J. W.: Proc. 1968 Deuel Conf. on Lipids on The Turnover of Lipids and Lipoproteins, Feb. 21–24, 1968, Carmel, Calif., p 124 (1968).Google Scholar
  113. Farquhar, J. W., Frank, A., Gross, R. C., Reaven, G. M.: Glucose, insulin, and triglyceride response to high and low carbohydrate diets in man. J. clin. Invest. 45, 1648–1656 (1966).PubMedGoogle Scholar
  114. Farquhar, J. W., Gross, R. C., Wagner, R. W., Reaven, G. M.: Validation of an incompletely coupled two-compartment nonrecycling catenary model for turnover of liver and plasma triglyceride in man. J. Lipid. Res. 6, 119–134 (1965).PubMedGoogle Scholar
  115. Farquhar, J. W., Reaven, G. M., Gross, R., Wagner, R.: Rate of plasma triglyceride synthesis in carbohydrate-induced lipemia. J. clin. Invest. 42, 930–931 (1963).Google Scholar
  116. Feigelson, E. B., Pfaff, W. W., Karmen, A., Steinberg, D.: The role of plasma free fatty acids in development of fatty liver. J. clin. Invest. 40, 2171–2179 (1961).PubMedGoogle Scholar
  117. Felts, J. M., Mayes, P. A.: Lack of uptake and oxidation of chylomicron triglyceride to carbon dioxide and ketone bodies by the perfused rat liver. Nature (Lond.) 206, 195–196 (1965).Google Scholar
  118. Fillios, L. C., Naito, C., Andrus, S. B., Portman, O. W., Martin, R. S.: Variations in cardiovascular sudanophilia with changes in the dietary level of protein. Amer. J. Physiol. 194, 275–279 (1958).PubMedGoogle Scholar
  119. Fine, M. B., Williams, R. H.: Effect of fasting, epinephrine and glucose and insulin on hepatic uptake of nonesterified fatty acids. Amer. J. Physiol. 199, 403–406 (1960).PubMedGoogle Scholar
  120. Fine, M. B., Michaels, G., Shah, S., Chai, B., Fukayama, G., Kinsell, L.: The incorporation of C14 from uniformly labeled glucose into plasma triglycerides in normals and hyper-glyceridemics. Metabolism 11, 893–911 (1962).PubMedGoogle Scholar
  121. Fredrickson, D. S., Gordon, R. S., Jr.: Metabolism of albumin-bound labeled fatty acids in man. J. clin. Invest. 36, 890 (1957).Google Scholar
  122. Fredrickson, D. S., Lees, R. S.: A system for phenotyping hyperlipoproteinemia. Circulation 31, 312–327 (1965).Google Scholar
  123. Fredrickson, D. S., Lees, R. S.: Familial Hyperlipoproteinemia. In: The Metabolic Basis of Inherited Disease. Sec. Ed. Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S. (Hrsg.), pp. 429–485, New York: McGraw-Hill 1966.Google Scholar
  124. Fredrickson, D. S., Gordon, R. S., Jr., Ono, K., Cherkes, A.: The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects. J. clin. Invest. 37, 1504–1515 (1958b).PubMedGoogle Scholar
  125. Fredrickson, D. S., Levy, R. I., Lees, R. S.: Fat transport in lipoproteins — an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 32–44, 94–103, 148–156, 215–226, 273–281 (1967).Google Scholar
  126. Fredrickson, D. S., McCollester, D. L., Havel, R. J., Ono, K.: The early steps in transport and metabolism of exogenous triglyceride and cholesterol. In: Chemistry of Lipids as Related to Atherosclerosis, Page, I. H. (Hrsg.) pp. 205–221, Springfield, Mass.: Charles CThomas 1958a.Google Scholar
  127. Fredrickson, D. S., Ono, K., Davis, L. L.: Lipolytic activity of post-heparin plasma in hyperglyceridemia. J. Lipid Res. 4, 24–33 (1963).PubMedGoogle Scholar
  128. French, J. E., Morris, B.: The removal of 14C-labelled chylomicron fat from the circulation in rats. J. Physiol. (Lond.) 138, 326–339 (1957).Google Scholar
  129. French, J. E., Morris, B.: The tissue distribution and oxidation of C14-labelled chylomicron fat injected intravenously in rats. J. Physiol. (Lond.) 140, 262–271 (1958).Google Scholar
  130. Friedberg, S. J., Estes, E. H., Jr.: Direct evidence for the oxidation of free fatty acids by peripheral tissues. J. clin. Invest. 41, 677–681 (1962).PubMedGoogle Scholar
  131. Friedberg, S. J., Harlan, W. R., Jr., Trout, D. L., Estes, E. H., Jr.: The effect of exercise on the concentration and turnover of plasma nonesterified fatty acids. J. clin. Invest. 39, 215–220 (1960).PubMedGoogle Scholar
  132. Friedberg, S. J., Klein, R. F., Trout, D. L., Bogdonoff, M. D., Estes, E. H., Jr.: The incorporation of plasma free fatty acids into plasma triglycerides in man. J. clin. Invest. 40, 1846–1855 (1961).PubMedGoogle Scholar
  133. Friedman, M., Byers, S. O.: Observations concerning the production and excretion of cholesterol in mammals. XVI. The relationship of the liver to the content and control of plasma cholesterol ester. J. clin. Invest. 34, 1369–1374 (1955).PubMedGoogle Scholar
  134. Fritz, I. B., Davis, D. G., Holtrop, R. H., Dundee, H.: Fatty acid oxidation by skeletal muscle during rest and activity. Amer. J. Physiol. 194, 379–386 (1958).PubMedGoogle Scholar
  135. Furman, R. H., Howard, R. P., Alaupovic, P.: Effect of chronic heparin administration on serum lipids, lipoproteins, nitrogen and electrolyte balance in normal and heparin-responsive and heparin-unresponsive hyperglyceridemic subjects. Metabolism 11, 879–892 (1962).PubMedGoogle Scholar
  136. Furman, R. H., Howard, R. P., Brusco, O. J., Alaupovic, P.: Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced) and dietary carbohydrate-accentuated lipemia. J. Lab. clin. Med. 66, 912–926 (1965).PubMedGoogle Scholar
  137. Furman, R. H., Howard, R. P., Lakshmi, K., Norcia, L. N.: The serum lipids and lipoproteins in normal and hyperlipidemic subjects as determined by preparative ultracentrifugation. Effects of dietary and therapeutic measures. Changes induced by in vitro exposure of serum to sonic forces. Amer. J. clin. Nutr. 9, 73–102 (1961).PubMedGoogle Scholar
  138. Gage, S. H., Fish, P. A.: Fat digestion, absorption, and assimilation in man and animals as determined by the dark-field microscope, and a fat-soluble dye. Amer. J. Anat. 34, 1–85 (1924).Google Scholar
  139. Gelb, A. M., Davidson, M. I., Kessler, J. I.: Effect of fasting on esterification of fatty acids by the small intestine in vitro. Amer. J. Physiol. 207, 1207–1210 (1964).PubMedGoogle Scholar
  140. Gidez, L. I., Roheim, P. S., Eder, H. A.: Effect of plasma free fatty acid concentrations on triglyceride synthesis by the perfused liver. Fed. Proc. 21, 289 (1962).Google Scholar
  141. Glueck, C. J., Levy, R. I., Fredrickson, D. S.: Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, III, IV, and V hyperlipoproteinemia. Diabetes 18, 739–747 (1969).PubMedGoogle Scholar
  142. Goetz, F. C., Maney, J. W., Greenberg, B. Z.: The regulation of insulin secretion: Effects of the infusion of glucose, ribose, and other sugars into the portal veins of dog. J. Lab. Clin. Med. 69, 537–557 (1967).PubMedGoogle Scholar
  143. Gofman,J. W., Lindgren, F. T., Elliott, H.: Ultracentrifugai studies of lipoproteins of human serum. J. biol. Chem. 179, 973–979 (1949).PubMedGoogle Scholar
  144. Goodman, D. S., Shiratori, T.: In vivo turnover of different cholesterol esters in rat liver and plasma. J. Lipid Res. 5, 578–586 (1964).PubMedGoogle Scholar
  145. Gordis, E.: Demonstration of two kinds of fat particles in alimentary lipemia with polyvinylpyrrolidone gradient columns. Proc. Soc. exp. Biol. (N. Y.) 110, 657–661 (1962).Google Scholar
  146. Gordis, E.: Preservation of dietary triglycerides in the secondary particles of alimentary lipemia. J. clin. Invest. 44, 1451–1457 (1965).PubMedGoogle Scholar
  147. Gordon, R. S., Jr., Cherkes, A.: Unesterified fatty acid in human blood plasma. J. clin. Invest. 35, 206–212 (1956).PubMedGoogle Scholar
  148. Gordon, R. S., Jr., Cherkes, A.: Production of unesterified fatty acids from isolated rat adipose tissue incubated in vitro. Proc. Soc. exp. Biol. (N. Y.) 97, 150–151 (1958).Google Scholar
  149. Gordon, R. S., Jr., Cherkes, A., Gates, H.: Unesterified fatty acid in human blood plasma. II. The transport function of unesterified fatty acid. J. clin. Invest. 36, 810–815 (1957).PubMedGoogle Scholar
  150. Gousios, A., Felts, J. M., Havel, R. J.: The metabolism of serum triglycerides and free fatty acids by the myocardium. Metabolism 12, 75–80 (1963).PubMedGoogle Scholar
  151. Gries, F. A., Potthoff, S., Jahnke, K.: Effects of insulin on the metabolism of triglycerides. Fifth Congress of the International Diabetes Federation. Toronto, July 20–24, 1964. Excerpta med. 74, 12 (1964).Google Scholar
  152. Grodsky, G. M., Batts, A. A., Bennet, L. L., Ucella, C., McWilliams, N. B., Smith, D. F.: Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Amer. J. Physiol. 205, 638–644 (1963).PubMedGoogle Scholar
  153. Gustafson, A.: Studies on human serum very-low-density-lipoproteins. Acta med. scand. Suppl. 446, 1–44 (1966).Google Scholar
  154. Gustafson, A., Alaupovic, P., Furman, R. H.: Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry 5, 632–640 (1966).PubMedGoogle Scholar
  155. Gutman, A., Landau, S., Shafrir, E.: Uptake of lipoprotein triglyceride by rat adipose tissue in vitro. Bull. Res. Coun. Israel A 11, 91 (1962).Google Scholar
  156. Haessler, H. A., Isselbacher, J.K. J.: Glycerokinase and its relation to intestinal glycerol metabolism. Fed. Proc. 22, 357 (1963).Google Scholar
  157. Hahn, P. F.: Abolishment of alimentary lipemia following injection of heparin. Science 98, 19–20 (1943).PubMedGoogle Scholar
  158. Hallberg, D.: Studies on the elimination of exogenous lipids from the blood stream. Determination and separation of the plasma triglycerides after single injection of a fat emulsion in man. Acta physiol. scand. 62, 407–421 (1964).PubMedGoogle Scholar
  159. Hallberg, D.: Studies on the elimination of exogenous lipids from the blood stream. The kinetics for the elimination of a fat emulsion studied by single injection technique in man. Acta physiol. scand. 64, 306–313 (1965).PubMedGoogle Scholar
  160. Hamilton, R. L., Regen, D. M., Gray, M. E., Lequire, V. S.: Lipid transport in liver. I. Electron microscopic identification of very low density lipoproteins in perfused rat liver. Lab. Invest. 16, 305–319 (1967).PubMedGoogle Scholar
  161. Harlan, W. R., Jr., Winesett, P. S., Wasserman, A. J.: Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat. J. clin. Invest. 46, 239–247 (1967).PubMedGoogle Scholar
  162. Hatch, F. T.: Serum lipoproteins. In: Serum Proteins and the Dysproteinemias. Sunderman, F. W., Sunderman, F. W., Jr., (Hrsg.), p. 223, Philadelphia: Lippincott 1964.Google Scholar
  163. Hatch, F. T., Abell, L. L., Kendall, F. E.: Effects of restriction of dietary fat and cholesterol upon serum lipids and lipoproteins in patients with hypertension. Amer. J. Med. 19, 48–60 (1955).PubMedGoogle Scholar
  164. Hatch, F. T., Hagopian, L. M., Rubenstein, J. J., Canellos, G. P.: Incorporation of labeled leucine into lipoprotein protein by rat intestinal mucosa. Circulation 28, 659 (1963).Google Scholar
  165. Havel, R. J.: Early effects of fasting and of carbohydrate ingestion on lipids and lipoproteins of serum in man. J. clin. Invest. 36, 855–859 (1957).PubMedGoogle Scholar
  166. Hatch, F. T., Conversion of plasma free fatty acids into triglycerides of plasma lipoprotein fractions in man. Metabolism 10, 1031–1034 (1961).Google Scholar
  167. Hatch, F. T., Triglyceride and very low density lipoprotein turnover. Proc. 1968 Deuel Conf. on Lipids on the Turnover of Lipids and Lipoproteins, Carmel (Calif.), Feb. 21–24, 1968, p 117–121 (1968).Google Scholar
  168. Hatch, F. T., Metabolism of plasma triglycerides. Second International Symposium on Atherosclerosis, Chicago, Ill. Nov. 2–5, 1969.Google Scholar
  169. Hatch, F. T., Clarke, J. C.: Metabolism of chylomicron phospholipids. Clin. Res. 6, 264–265 (1958).Google Scholar
  170. Hatch, F. T., Fredrickson, D. S.: The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma. J. clin. Invest. 35, 1025–1032 (1956).Google Scholar
  171. Hatch, F. T., Goldfien, A.: The role of the sympathetic nervous system in the metabolism of free fatty acids. J. Lipid. Res. 1, 102–108 (1959).Google Scholar
  172. Hatch, F. T., Goldfien, A.: The role of the liver and extrahepatic tissues in the transport and metabolism of fatty acids and triglycerides in the dog. J. Lipid Res. 2, 389–395 (1961).Google Scholar
  173. Hatch, F. T., Gordon, R. S., Jr.: Idiopathic hyperlipemia: Metabolic studies in an affected family. J. clin. Invest. 39, 1777–1790 (1960).Google Scholar
  174. Hatch, F. T., Eder, H. A., Bragdon, J. H.: The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. J. clin. Invest. 34, 1345–1353 (1955).Google Scholar
  175. Hatch, F. T., Felts, J. M., Bezman, A.: Demonstration of lipoprotein lipase in human adipose tissue. Clin. Res. 9, 72 (1961).Google Scholar
  176. Hatch, F. T., Felts, J. M., van Duyne, C M.: Formation and fate of endogenous triglyceride in blood plasma of rabbits. J. Lipid Res. 3, 297–308 (1962).Google Scholar
  177. Hatch, F. T., Naimark, S., Borchgrevink, C F.: Turnover rate and oxidation of free fatty acids of blood plasma in man during exercise: Studies during continuous infusion of palmitate-1-C14. J. clin. Invest. 42, 1054–1063 (1963).Google Scholar
  178. Haymond, T. A., Berry, K. Jr.: Persistent hyperlipemia and hepatosplenomegaly in a patient with controlled diabetes mellitus. Ann. Int. Med. 41, 609–616 (1954).PubMedGoogle Scholar
  179. Hazelwood, R. N.: Molecular weights and dimensions of some high-density human serum lipoproteins. J. Amer. Chem. Soc. 80, 2152–2156 (1958).Google Scholar
  180. Heimberg, M., Meng, H. C., Park, C. R.: Effect of sex, fasting and alloxan diabetes on the uptake of neutral fat by isolated perfused rat liver. Amer. J. Physiol. 195, 673–677 (1958).PubMedGoogle Scholar
  181. Hewitt, J. E., Hayes, T. L., Gofman, J. W., Jones, H. B., Pierce, F. T.: Effects of total body irradiation upon lipoprotein metabolism. Cardiologia 21, 353–365 (1952).PubMedGoogle Scholar
  182. Hillyard, L. A., Cornelius, C E., Chaikoff, I. L.: Removal by the isolated rat liver of palmitate-1-C14 bound to albumin and of palmitate-1-C14 and cholesterol-4-C14 in chylomicrons from perfusion fluid. J. biol. Chem. 234, 2240–2245 (1959).PubMedGoogle Scholar
  183. Hodges, R. E., Krehl, W. A.: The role of carbohydrates in lipid metabolism. Amer. J. clin. Nutr. 17, 334–346 (1965).PubMedGoogle Scholar
  184. Hofmann, A. F., Borgström, B.: Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21, 43–50 (1962).PubMedGoogle Scholar
  185. Hollenberg, C. H.: Effect of nutrition on activity and release of lipase from rat adipose tissue. Amer. J. Physiol. 197, 667–670 (1959).PubMedGoogle Scholar
  186. Hollenberg, C. H.: The effect of fasting on the lipoprotein lipase activity of rat heart and diaphragm. J. clin. Invest. 39, 1282–1287 (1960).PubMedGoogle Scholar
  187. Holt, L. E., Jr., Aylward, F. Y., Timbres, H. G.: Idiopathic familial lipemia. Bull. Johns Hopk. Hosp. 64, 279–314 (1939).Google Scholar
  188. Holt, P. R.: Utilization of glycerol-C14 for intestinal glyceride esterifkation: Studies in a patient with chyluria. J. clin. Invest. 43, 349–356 (1964).PubMedGoogle Scholar
  189. Hug, G., Schubert, W. K.: Serum insulin in type I glycogenosis. Effect of galactose or fructose administration. Diabetes 16, 791–795 (1967).PubMedGoogle Scholar
  190. Isselbacher, K. J., Budz, D. M.: Synthesis of lipoproteins by rat intestinal mucosa. Nature (Lond.) 200, 364–365 (1963).Google Scholar
  191. Jahnke, K.: Pathophysiologische und klinische Aspekte des Fettstoffwechsels. Symposium 25. April — 5. Mai 1965, Heidelberg. Schettler, G., Sanwald, R. (Hrsg.), Stuttgart: Thieme 1966.Google Scholar
  192. Jedeikin, L. A., Weinhouse, S.: Studies of the incorporation of palmitate-1-C14 into tissue lipides in vitro. Arch. Biochem. 50, 134–147 (1954).Google Scholar
  193. Jeffries, G. H.: The effect of fat absorption on the interaction of chyle and plasma in the rat. Quart. J. exp. Physiol. 39, 77–81 (1954a).PubMedGoogle Scholar
  194. Jeffries, G. H.: The site at which plasma clearing activity is produced and distroyed in the rat. Quart. J. exp. Physiol. 39, 261–265 (1954b).PubMedGoogle Scholar
  195. Jencks, W. P., Hyatt, M. R., Jetton, M. R., Mattingly, T. W., Durrum, E. L.: A study of serum lipoproteins in normal and atherosclerotic patients by paper electrophoretic techniques. J. clin. Invest. 35, 980–990 (1956).PubMedGoogle Scholar
  196. Jones, A. L., Ruderman, N. B., Herrera, M. G.: An electron microscopic study of lipoprotein production and release by the isolated perfused rat liver. Proc. Soc. exp. Biol. (N. Y.) 123, 4–9 (1966).Google Scholar
  197. Jones, A. L., Ruderman, N. B., Herrera, M. G.: Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J. Lipid Res. 8, 429–446 (1967).PubMedGoogle Scholar
  198. Jones, D. P., Arky, R. A.: Effects of insulin on triglyceride and free fatty acid metabolism in man. Metabolism 14, 1287–1293 (1965).PubMedGoogle Scholar
  199. Kane, J. P., Longcope, C., Pavlatos, F. C., Grodsky, G. M.: Studies of carbohydrate metabolism in idiopathic hypertriglyceridemia. Metabolism 14, 471–486 (1965).PubMedGoogle Scholar
  200. Karmen, A., Whyte, M., Goodman, D. S.: Fatty acid esterifkation and chylomicron formation during fat absorption. 1. Triglycerides and cholesterol esters. J. Lipid Res.4, 312–321 (1963).PubMedGoogle Scholar
  201. Katz, J., Wood, H. G.: The use of glucose-C14 for the evaluation of the pathways of glucose metabolism. J. biol. Chem. 235, 2165–2177 (1960).PubMedGoogle Scholar
  202. Kafmann, N. A., Poznanski, R., Blondheim, S. H., Stein, Y.: Changes in serum lipid levels of hyperlipemic patients following the feeding of starch, sucrose and glucose. Amer. J. clin. Nutr. 18, 261–269 (1966).Google Scholar
  203. Kay, R. E., Entenman, C.: The synthesis of “chylomicron-like” bodies and maintenance of normal blood sugar levels by the isolated, perfused rat liver. J. biol. Chem. 236, 1006–1012 (1961).PubMedGoogle Scholar
  204. Kayden, H. J., Karmen, A., Dumont, A.: Alteration in the fatty acid composition of human lymph and serum lipoproteins by single feedings. J. clin. Invest. 42, 1373–1381 (1963).PubMedGoogle Scholar
  205. Kennedy, E. P.: Synthesis of phosphatides in isolated mitochondria. J. biol. Chem. 201, 399–412 (1953).PubMedGoogle Scholar
  206. Kessler, J. I.: Effect of diabetes and insulin on the activity of myocardial and adipose tissue lipoprotein lipase of rats. J. clin. Invest. 42, 362–367 (1963).PubMedGoogle Scholar
  207. Kessler, J. I., Kniffen, J. C., Janowitz, H. D.: Lipoprotein lipase inhibition in the hyperlipemia of acute alcoholic pancreatitis. New Engl. J. Med. 269, 943–948 (1963).PubMedGoogle Scholar
  208. Keys, A., Anderson, J. T., Grande, F.: Diet-type (fats constant) and blood lipids in man. J. Nutr. 70, 257–266 (1960).PubMedGoogle Scholar
  209. Klatskin, G., Gordon, M.: Relationship between relapsing pancreatitis and essential hyperlipemia. Amer. J. Med. 12, 3–23 (1952).PubMedGoogle Scholar
  210. Klein, E., Lever, W. F.: Inhibition of lipemia clearing activity by serum of patients with hyperlipemia. Proc. Soc. exp. Biol. (N. Y.) 95, 565–567 (1957).Google Scholar
  211. Klein, E., Lever, W. F., Fekete, L. L.: Defective lipemia clearing response to heparin in idiopathic hyperlipemia. J. invest. Derm. 33, 91–96 (1959).PubMedGoogle Scholar
  212. Knittle, J. L., Ahrens, E. H., Jr.: Carbohydrate metabolism in two forms of hyperglyceridemia. J. clin. Invest. 43, 485–495 (1964).PubMedGoogle Scholar
  213. Korn, E. D.: Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. biol. Chem. 215, 1–14 (1955 a).PubMedGoogle Scholar
  214. Korn, E. D.: Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. biol. Chem. 215, 15–26 (1955b).PubMedGoogle Scholar
  215. Korn, E. D., Quigley, T. W., Jr.: Studies on lipoprotein lipase of rat heart and adipose tissue. Biochim. biophys. Acta (Amst.) 18, 143–145 (1955).Google Scholar
  216. Korn, E. D., Quigley, T. W., Jr.: Lipoprotein lipase of chicken adipose tissue. J. biol. Chem. 226, 833–839 (1957).PubMedGoogle Scholar
  217. Kornberg, A., Pricer, W. E., Jr.: Enzymatic synthesis of the coenzyme A derivatives of long chain fatty acids. J. biol. Chem. 204, 329–343 (1953 a).PubMedGoogle Scholar
  218. Korn, E. D., Quigley, T. W., Jr.: Enzymatic esterification of α-glycerophosphate by long chain fatty acids. J. biol. Chem. 204, 345–357 (1953b).Google Scholar
  219. Kunkel, H. G., Slater, R. J.: Zone electrophoresis in a starch supporting medium. Proc. Soc. exp. Biol. (N. Y.) 80, 42–44 (1952).Google Scholar
  220. Kunkel, H. G., Trautman, R.: The α 2 lipoproteins of human serum. Correlation of ultracentrifugai and electrophoretic properties. J. clin. Invest. 35, 641–648 (1956).PubMedGoogle Scholar
  221. Kuo, P. T.: Dietary sugar in the production of hyperglyceridemia in patients with hyperlipemia and atherosclerosis. Trans. Ass. Amer. Phycns 78, 97–116 (1965).Google Scholar
  222. Kuo, P. T., Bassett, D. R.: Dietary sugar in the production of hyperglyceridemia. Ann. int. Med. 62, 1199–1212 (1965).PubMedGoogle Scholar
  223. Kuo, P. T., Carson, J. C.: Dietary fats and the diurnal serum triglyceride levels in man. J. clin. Invest. 38, 1384–1393 (1959).PubMedGoogle Scholar
  224. Kuo, P. T., Bassett, D. R., di George, A. M., Carpenter, G. G.: Lipolytic activity of post-heparin plasma in hyperlipemia and hypolipemia. Circulation Res. 16, 221–229 (1965).PubMedGoogle Scholar
  225. Kuo, P. T., Whereat, A. F., Horwitz, O.: The effect of lipemia upon coronary and peripheral arterial circulation in patients with essential hyperlipemia. Amer. J. Med. 26, 68–75 (1959).PubMedGoogle Scholar
  226. de Lalla, O. F., Gofman, J. W.: Ultracentrifugai analysis of serum lipoproteins. In: Methods of Biochemical Analysis, D. Glick (Hrsg.), Vol. 1, p. 459. New York: Inter-science 1954.Google Scholar
  227. Laurell, S.: Turnover rate of unesterified fatty acids in human plasma. Acta physiol. scand. 41, 158–167 (1957).PubMedGoogle Scholar
  228. Laurell, S.: Recycling of intravenously injected palmitic acid-l-C14 as esterified fatty acid in the plasma of rats and turnover rate of plasma triglycerides. Acta physiol. scand. 47, 218–232 (1959).PubMedGoogle Scholar
  229. Lees, R. S.: The plasma lipid response to two types of dietary carbohydrate. Clin. Res. 13, 549 (1965).Google Scholar
  230. Laurell, S., Fredrickson, D. S.: The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis. J. clin. Invest. 44, 1968–1977 (1965 a).Google Scholar
  231. Laurell, S., Fredrickson, D. S.: Carbohydrate induction of hyperlipemia in normal man. Clin. Res. 13, 327 (1965 b).Google Scholar
  232. Laurell, S., Hatch, F. T.: Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J. Lab. clin. Med. 61, 518–528 (1963).Google Scholar
  233. Lequire, V. S., Hamilton, R. L., Adams, R., Merrill, J. M.: Lipase activity in blood from the hepatic and peripheral vascular beds following heparin. Proc. Soc. exp. Biol. (N. Y.) 114, 104–107 (1963).Google Scholar
  234. Lever, W. F., Smith, P. A. J., Hurley, N. A.: Idiopathic hyperlipemic and primary hypercholesteremic xanthomatosis. I. Clinical data and analysis of the plasma lipids. J. Invest. Dermat. 22, 33–51 (1954).Google Scholar
  235. Levy, R. I., Lees, R. S., Fredrickson, D. S.: The nature of pre-beta (very low density) lipoproteins. J. clin. Invest. 45, 63–77 (1966).PubMedGoogle Scholar
  236. Lynch, H. T., Kaplan, A. R., Henn, M. J., Krush, A. J.: Familial coexistence of diabetes mellitus, hyperlipemia, short stature, and hypogonadism. Amer. J. Med. Sci. 252, 323–330 (1966).PubMedGoogle Scholar
  237. Macdonald, I.: The lipid response of young women to dietary carbohydrates. Amer. J. clin. Nutr. 16, 458–463 (1965 a).PubMedGoogle Scholar
  238. Macdonald, I.: The effects of various dietary carbohydrates on the serum lipids during five-day regimen. Clin. Sci. 29, 193–197 (1965 b).PubMedGoogle Scholar
  239. Macdonald, I.: Dietary fructose and serum lipid levels in man. Proc. Nutr. Soc. 25, ii (1966a).Google Scholar
  240. Macdonald, I.: Influence of fructose and glucose on serum lipid levels in men and pre- and postmenopausal women. Amer. J. clin. Nutr. 18, 369–372 (1966 b).PubMedGoogle Scholar
  241. Macdonald, I.: The lipid response of postmenopausal women to dietary carbohydrates. Amer. J. clin. Nutr. 18, 86–90 (1966 c).PubMedGoogle Scholar
  242. Macdonald, I.: Ingested glucose and fructose in serum lipids in healthy men and after myocardial infarction. Amer. J. clin. Nutr. 21, 1366–1373 (1968).PubMedGoogle Scholar
  243. Macdonald, I.: Braithwaite, D. M.: The influence of dietary carbohydrates on the lipid pattern in serum and in adipose tissue. Clin. Sci. 27, 23–30 (1964).PubMedGoogle Scholar
  244. Macdonald, I.: Roberts, J. B.: The incorporation of various C14 dietary carbohydrates into serum and liver lipids. Metabolism 14, 991–999 (1965).PubMedGoogle Scholar
  245. Marshall, F. N.: Lipoprotein lipase activity in normal human adipose tissue and its absence in human lipomas. Experientia (Basel) 21, 130–133 (1965).Google Scholar
  246. Masoro, E. J., Chaikoff, I. L., Chernick, S. S., Felts, J. M.: Previous nutritional state and glucose conversion to fatty acids in liver slices. J. biol. Chem. 185, 845–856 (1950).PubMedGoogle Scholar
  247. Mattson, F. H., Beck, L. W.: The digestion in vitro of triglycerides by pancreatic lipase. J. biol. Chem. 214, 115–125 (1955).PubMedGoogle Scholar
  248. Mattson, F. H., Volpenhein, R. A.: The digestion and absorption of triglycerides. J. biol. Chem. 239, 2772–2777 (1964).PubMedGoogle Scholar
  249. McCalla, C., Gates, H. S., Jr., Gordon, R. S., Jr.: C14O2 excretion after the intravenous administration of albumin-bound palmitate-1-C14 to intact rats. Arch. Biochem. 71, 346–351 (1957).Google Scholar
  250. McElroy, W. T., Jr., Siefert, W. L., Spitzer, J. J.: Relationship of hepatic uptake of free fatty acids to plasma concentration. Proc. Soc. exp. Biol. (N. Y.) 104, 20–23 (1960).Google Scholar
  251. Muntz, J. A., Vanko, M.: The metabolism of intraportally injected fructose in rat liver in vivo. J. biol. Chem. 237, 3582–3587 (1962).PubMedGoogle Scholar
  252. Murray, R. G., Freeman, S.: The morphologic distribution of intravenously injected fatty chyle and artificial fat emulsion in rats and dogs. J. Lab. clin. Med. 38, 56–69 (1951).PubMedGoogle Scholar
  253. Nerking, J.: Über Fetteiweißverbindungen. Pflügers Arch. ges. Physiol. 85, 330–344 (1901).Google Scholar
  254. Nestel, P. J.: Relationship between plasma triglycerides and removal of chylomicrons. J. clin. Invest. 43, 943–949 (1964a).PubMedGoogle Scholar
  255. Nestel, P. J.: Plasma triglyceride concentration and plasma free fatty acid changes in response to norepinephrine in man. J. clin. Invest. 43, 77–82 (1964b)PubMedGoogle Scholar
  256. Nestel, P. J.: Triglyceride turnover in coronary heart disease and the effect of dietary carbohydrate. Clin. Sci. 31, 31–38 (1966).PubMedGoogle Scholar
  257. Nestel, P. J.: Relationship between FFA flux and TGFA influx in plasma before and during the infusion of insulin. Metabolism 16, 1123–1132 (1967).PubMedGoogle Scholar
  258. Nestel, P. J.: Havel, R. J.: Lipoprotein lipase in human adipose tissue. Proc. Soc. exp. Biol. (N. Y.) 109, 985–987 (1962).Google Scholar
  259. Nestel, P. J.: Scow, R. O.: Metabolism of chylomicrons of differing triglyceride composition. J. Lipid Res. 5, 46–51 (1964).Google Scholar
  260. Nestel, P. J., Steinberg, D.: Fate of palmitate and linoleate perfused through the isolated rat liver at high concentrations. J. Lipid Res. 4, 461–469 (1963).PubMedGoogle Scholar
  261. Nestel, P. J., Austin, W., Foxman, C.: Lipoprotein lipase content and triglyceride fatty acid uptake in adipose tissue of rats of differing body weights. J. Lipid Res. 10, 383–387 (1969).PubMedGoogle Scholar
  262. Nestel, P. J., Havel, R. J., Bezman, A.: Sites of initial removal of chylomicron triglyceride fatty acids from the blood. J. clin. Invest. 41, 1915–1921 (1962).PubMedGoogle Scholar
  263. Nikkilä, E.: Studies on lipid-protein relationships in normal and pathological sera and the effect of heparin on serum lipoprotein. Scand. J. clin. Lab. Invest. 5 (Suppl. 8), 1–101 (1953).Google Scholar
  264. Nikkilä, E., Ojala, K.: Induction of hyperglyceridemia by fructose in the rat. Life Sci. 4, 937–943 (1965).PubMedGoogle Scholar
  265. Nikkilä, E., Ojala, K.: Acute effects of fructose and glucose on the concentration and removal rate of plasma triglyceride. Life Sci. 5, 89–94 (1966).PubMedGoogle Scholar
  266. Nikkilä, E., Pelkonen, R., Miettinen, A.: Relationship between glucose metabolism and serum triglyceride and cholesterol levels. Diabetologia 2, 232 (1966).Google Scholar
  267. Nilsson, S., Scherstén, T.: Synthesis of phospholipids and triglycerides in human liver slices. I. Experimental conditions and the synthesis rate in normal liver tissue. Scand. J. clin. Lab. Invest. 24, 237–249 (1969).PubMedGoogle Scholar
  268. Nye, W. H. R.: An assessment of the role of alpha and beta chylomicra in hyperlipemic states. Proc. Soc. exp. Biol. (N. Y.) 116, 350–354 (1964).Google Scholar
  269. Olivecrona, T.: Metabolism of chylomicrons labeled with C14-glycerol-H3-palmitic acid in the rat. J. Lipid Res. 3, 439–444 (1962).Google Scholar
  270. Östman, J.: Inhibitory effect of nicotinic acid on FFA mobilization in alloxan-diabetic rats. I. In vitro studies on the fatty acid metabolism in adipose tissue after nicotinic acid administration to donor animals. Acta med. scand. 177, 615–621 (1965).PubMedGoogle Scholar
  271. Patten, R. L., Hollenberg, C. H.: The mechanism of heparin stimulation of rat adipocyte lipoprotein lipase. J. Lipid Res. 10, 374–382 (1969).PubMedGoogle Scholar
  272. Pav, J., Wenkeova, J.: Significance of adipose tissue lipoprotein lipase. Nature (Lond.) 185, 926–927 (1960).Google Scholar
  273. Persson, B., BjÖrntorp, P., Hood, B.: Lipoprotein lipase activity in human adipose tissue. I. Conditions for release and relationship to triglycerides in serum. Metabolism 15, 730–741 (1966).PubMedGoogle Scholar
  274. Pinter, G. G., Zilversmit, D. B.: A gradient centrifugation method for determination of particle size distribution of chylomicrons and of fat droplets in artificial fat emulsions. Biochim. biophys. Acta (Amst.) 59, 116–127 (1962).Google Scholar
  275. Porte, D., Entenman, C.: Fatty acid metabolism in rat intestinal segments. U. S. Naval radiol. Def. Lab. Tech. Dept. 526, 1–35 (1961).Google Scholar
  276. Porte, D., Jr., O’Hara, D. D., Williams, R. H.: The relation between postheparin lipolytic activity and plasma triglyceride in myxedema. Metabolism 15, 107–113 (1966).PubMedGoogle Scholar
  277. Quarfordt, S. H., Goodman, D. S.: Heterogeneity in the rate of plasma clearance of chylomicrons of different size. Biochim. biophys. Acta (Amst.) 116, 382–385 (1966).Google Scholar
  278. Quarfordt, S. H., Frank, A., Shames, D. M., Berman, M., Steinberg, D.: Turnover of triglycerides in very low density lipoproteins (VLDL) in hyperlipoproteinemia. Clin. Res. 18, 187 (1970).Google Scholar
  279. Reaven, G., Calciano, A., Cody, R., Lucas, C., Miller, R.: Carbohydrate intolerance and hyperlipemia in patients with moycardial infarction without known diabetes mellitus. J. clin. Endocr. 23, 1013–1023 (1963).PubMedGoogle Scholar
  280. Reaven, G., Farquhar, J. W., Salans, L. E., Gross, R. C., Wagner, R. M.: Carbohydrate-induced lipemia. Clin. Res. 12, 277 (1964).Google Scholar
  281. Reaven, G., Frank, A., Gross, R., Salans, L., Farquhar, J.: Glucose and insulin metabolism in carbohydrate-induced lipemia. Clin. Res. 13, 332 (1965b).Google Scholar
  282. Reaven, G., Hill, D. B., Gross, R. C., Farquhar, J. W.: Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. J. clin. Invest. 44, 1826–1833 (1965a).PubMedGoogle Scholar
  283. Reaven, G., Lerner, R. L., Stern, M. P., Farquhar, J. W., Nakanishi, R.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest. 46, 1756–1767 (1967).PubMedGoogle Scholar
  284. Reiser, R., Bryson, M. J.: Route of absorption of free fatty acids and triglycerides from the intestine. J. biol. Chem. 189, 87–91 (1951).PubMedGoogle Scholar
  285. Reissel, P. K., Mandella, P. A., Poon-King, T. M. W., Hatch, F. T., Hagopian, L. M.: Treatment of hypertriglyceridemia. I. Total caloric restriction followed by refeeding a low carbohydrate, high fat diet in the carbohydrate-induced type (eight cases). II. Low fat diet plus medium-chain triglycerides in the fat-induced type (two cases). Amer. J. clin. Nutr. 19, 84–98 (1966).Google Scholar
  286. Rizack, M. A.: An epinephrine-sensitive lipolytic activity in adipose tissue. J. biol. Chem. 236, 657–662 (1961).Google Scholar
  287. Robinson, D. S., French, J. E.: Heparin, the clearing factor lipase, and fat transport. Pharmacol. Rev. 12, 241–263 (1960).PubMedGoogle Scholar
  288. Robinson, D. S., Harris, P. M.: The production of lipolytic activity in the circulation of the hind limb in response to heparin. Quart. J. exp. Physiol. 44, 80–90 (1959).PubMedGoogle Scholar
  289. Rodbell, M.: The removal and metabolism of chylomicrons by adipose tissue in vitro. J. biol. Chem. 235, 1613–1620 (1960).PubMedGoogle Scholar
  290. Rodbell, M.: Localization of lipoprotein lipase in fat cells of rat adipose tissue. J. biol. Chem. 239, 753–755 (1964).PubMedGoogle Scholar
  291. Rodbell, M., Fredrickson, D.S.: The nature of the proteins associated with dog and human chylomicrons. J. biol. Chem. 234, 562–566 (1959).PubMedGoogle Scholar
  292. Rodbell, M., Fredrickson, D.S., Ono, K.: Metabolism of chylomicron proteins in the dog. J. biol. Chem. 234, 567–571 (1959).PubMedGoogle Scholar
  293. Rodbell, M., Scow, R. O.: Metabolism of chylomicrons and triglyceride emulsions by perfused rat adipose tissue. Amer. J. Physiol. 208, 106–114 (1965).PubMedGoogle Scholar
  294. Rodbell, M., Scow, R. O., Chernick, S. S.: Removal and metabolism of triglycerides by perfused liver. J. biol. Chem. 239, 385–391 (1964).PubMedGoogle Scholar
  295. Roheim, P. S., Gidez, L. I., Eder, H. A.: Extrahepatic synthesis of lipoproteins of plasma and chyle: Role of the intestine. J. clin. Invest. 45, 297–300 (1966).PubMedGoogle Scholar
  296. Roheim, P. S., Haft, D. E., Gidez, L. L., White, A., Eder, H. A.: Plasma lipoprotein metabolism in perfused rat livers. II. Transfer of free and esterified cholesterol into the plasma. J. clin. Invest. 42, 1277–1285 (1963).PubMedGoogle Scholar
  297. Rose, G., Shapiro, B.: Enzyme systems in adipose tissue participating in fatty acid esteri-fication. Bull. Res. Coun. Israel A9, 15 (1960).Google Scholar
  298. Rose, H., Vaughan, M., Steinberg, D.: Utilization of fatty acids by rat liver slices as a function of medium concentration. Amer. J. Physiol. 206, 345–350 (1964).PubMedGoogle Scholar
  299. Rudas, B.: Das Verhalten der Serumlipide in verschiedenen Diabetesstadien der Ratte. Wien. klin. Wschr. 79, 377–382 (1967).PubMedGoogle Scholar
  300. Ryan, W. G., Schwartz, T. B.: Dynamics of plasma triglyceride turnover in man. Metabolism 14, 1243–1254 (1965).PubMedGoogle Scholar
  301. Sabesin, S. M., Isselbacher, K. J.: Protein synthesis inhibition: Mechanism for the production of impaired fat absorption. Science 147, 1149–1151 (1965).PubMedGoogle Scholar
  302. Sabesin, S. M., Drummey, G. D., Budz, D. M., Isselbacher, K. J.: Inhibition of protein synthesis: A mechanism for the production of impaired fat absorption. J. clin. Invest. 43, 1281 (1964).Google Scholar
  303. Sailer, S., Sandhofer, F., Braunsteiner, H.: Untersuchungen über die Lipoprotein-lipase. I. Mitteilung. Bestimmung der Post-Heparin-Lipoproteinlipase („Klärfaktor“) beim Menschen durch Messung der Triglyceridspaltung. Klin. Wschr. 39, 585–588 (1961).PubMedGoogle Scholar
  304. Sailer, S., Sandhofer, F., Braunsteiner, H.: Untersuchungen über die Lipoproteidlipase. V. Die Lipoproteidlipase im Herzmuskel von Ratten, Kaninchen und Menschen. Wien. klin. Wschr. 74, 9–11 (1962)PubMedGoogle Scholar
  305. Sailer, S., Sandhofer, F., Braunsteiner, H.: Steuerung der endogenen Lipoproteid-Lipase-Aktivität im Plasma bei Normalpersonen und Patienten mit essentieller Hyperlipämie. Dtsch. med. Wschr. 90, 865–868 (1965).PubMedGoogle Scholar
  306. Sailer, S., Sandhofer, F., Braunsteiner, H.:Umsatzraten für freie Fettsäuren und Triglyceride im Plasma bei essentieller Hyperlipämie. Klin. Wschr. 44, 1032–1036 (1966a).PubMedGoogle Scholar
  307. Sailer, S., Sandhofer, F., Braunsteiner, H.:Overweight and triglyceride level in normal persons and patients with diabetes mellitus. Metabolism 15, 135–137 (1966b).PubMedGoogle Scholar
  308. Sailer, S., Sandhofer, F., Braunsteiner, H.: Beziehungen zwischen Blutzuckerspiegel, Umsatzrate der freien Fettsäuren und Fettsäureeinbau in Plasmatriglyceride bei Diabetikern. Klin. Wschr. 45, 86–91 (1967 b).PubMedGoogle Scholar
  309. Sailer, S., Bolzano, K., Sandhofer, F., Spath, P., Braunsteiner, H.: Triglyceridspiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierter Hypertriglyceridämie. Schweiz med. Wschr. 98, 1512–1518 (1968a).PubMedGoogle Scholar
  310. Sailer, S., Sandhofer, F., Bolzano, K., Braunsteiner, H.: Über den Einfluß der Glucose auf den Umsatz der freien Fettsäuren des Plasmas, die Einbaurate der freien Fettsäuren in Plasmatriglyceride und die Wirkung von Noradrenalin auf diese Stoffwechselgrößen beim Menschen. Klin. Wschr. 45, 918–924 (1967a).PubMedGoogle Scholar
  311. Sailer, S., Sandhofer, F., Bolzano, K., Dienstl, F., Braunsteiner, H.: Über die Wirkung eines β-Blockers (Propranolol) auf den Umsatz der freien Fettsäuren und den Einbau von freien Fettsäuren in Plasmatriglyceride beim Menschen. Klin. Wschr. 45, 670–674 (1967 c).PubMedGoogle Scholar
  312. Sailer, S., Sandhofer, F., Bolzano, K., Braunsteiner, H.: Action of norepinephrine and propranolol on the turnover rate of free fatty acids and the esterification rate of free fatty acids to plasma triglycerides in man. Third International Symposium on Drugs Affecting Lipid Metabolism, Milan, Sept. 9–11, 1968 (b).Google Scholar
  313. Sailer, S., Sandhofer, F., Bolzano, K.: Diabetes mellitus und Hyperlipämie. In: Handbuch des Diabetes mellitus, Band II, Pfeiffer, E. F. (Hrsg.), München: J. F. Lehmanns Verlag, im Druck, 1970.Google Scholar
  314. Salaman, M. R.: zitiert nach Robinson, D. S.: Clearing factor lipase and fat transport. In: Advances in Lipid Research, Vol. 1, 145. Paoletti, R., Krichevsky, D. (Hrsg.), New York: Academic Press 1963.Google Scholar
  315. Salaman, M. R., Robinson, D. S.: Clearing-factor lipase in adipose tissue. A medium in which the enzyme activity of tissue from starved rats increases in vitro. Biochem. J. 99, 640–647 (1966).PubMedGoogle Scholar
  316. Salans, L. B., Reaven, G. M.: Effect of insulin pretreatment on glucose and lipid metabolism of liver slices from normal rats. Proc. Soc. exp. Biol. (N. Y.) 122, 1208–1213 (1966).Google Scholar
  317. Salt, H. B., Wolff, O. H., Lloyd, J. K., Fosbrooke, A. S., Cameron, A. H., Hubble, D. V.: On having no beta-lipoprotein: Syndrome comprising a-beta-lipoproteinemia, acanthocytosis, and steatorrhoea. Lancet 1960II, 325–329.Google Scholar
  318. Sanbar, S. S., Zweifler, A. J., Conway, F. J.: Carbohydrate metabolism in essential hyperlipidemia. Circulation 30, Suppl. III, 27 (1964).Google Scholar
  319. Sandhofer, F., Sailer, S., Braunsteiner, H.: Untersuchungen über die Lipoprotein- lipase. III. Mitteilung. Die Post-Heparin-Lipoproteinlipase beim Menschen unter normalen und pathologischen Bedingungen. Klin. Wschr. 39, 968–971 (1961 a).PubMedGoogle Scholar
  320. Sandhofer, F., Sailer, S., Braunsteiner, H.: Untersuchungen über endogene Lipoproteidlipaseaktivität. Klin. Wschr. 40, 855 (1962).PubMedGoogle Scholar
  321. Sandhofer, F., Sailer, S., Braunsteiner, H.: Fettsäure- und Triglyceridumsatz bei Schilddrüsenüberfunktion. Klin. Wschr. 44, 1389–1393 (1966a).PubMedGoogle Scholar
  322. Sandhofer, F., Sailer, S., Braunsteiner, H.: Fettsäure- und Triglyceridumsatz bei Patienten mit Leberzirrhose. Wien. klin. Wschr. 78, 731–733 (1966b).PubMedGoogle Scholar
  323. Sandhofer, F., Bolzano, K., Sailer, S., Braunsteiner, H.: Die Verwendung von Plasmaglucose- Kohlenstoff zur Bildung von Plasmatriglycerid-Glycerol bei Patienten mit primärer „kohlenhydratinduzierter“Hypertriglyceridämie. Klin. Wschr. 46, 1034–1038 (1968).PubMedGoogle Scholar
  324. Sandhofer, F., Bolzano, K., Sailer, S.: Quantitative Untersuchungen über den Einbau von Plasmaglucose-Kohlen-stoff in Plasmatriglyceride und die Veresterungsrate von freien Fettsäuren der Plasmas zu Plasmatriglyceriden während oraler Zufuhr von Glucose bei primärer kohlenhydratinduzierter Hypertriglyceridämie. Klin. Wschr. 47, 1086–1094 (1969).PubMedGoogle Scholar
  325. Sandhofer, F., Sailer, S., Braunsteiner, H., Braitenberg, H.: Post-Heparin-Lipoproteinlipase und Schwangerschaft. Untersuchungen über die Lipoproteinlipase. IL Wien. klin. Wschr. 73, 392–393 (1961b).Google Scholar
  326. Sandhofer, F., Sailer, S., Dienstl, F., Braunsteiner, H.: Über den Einfluß von Katecholaminen auf die Umsatzrate der freien Fettsäuren und die Bildung von Plasmatriglyceriden. Klin. Wschr. 45, 486–492 (1967).PubMedGoogle Scholar
  327. Sandhofer, F., Sailer, S., Herbst, M., Braunsteiner, H.: Untersuchungen über die Post-Heparin-Lipo-proteidlipase-Aktivität bei sechs Fällen von essentieller Hyperlipämie. Dtsch. med. Wschr. 90, 755–759 (1965).PubMedGoogle Scholar
  328. Sarda, L., Desnuelle. P.: Action de la lipase pancréatique sur les esters en émulsion. Biochim. biophys. Acta (Amst.) 30, 513–521 (1958).Google Scholar
  329. Schaefer, L. E.: Serum cholesterol-triglyceride distribution in a “normal” New York City population. Amer. J. Med. 36, 262–268 (1964).PubMedGoogle Scholar
  330. Schnatz, J. D., Williams, R. H.: Adipose tissue lipolytic activity during acute insulin lack. Clin. Res. 10, 118 (1962).Google Scholar
  331. Schnatz, J. D., Williams, R. H.:The effect of acute insulin deficiency in the rat on adipose tissue lipolytic activity and plasma lipids. Diabetes 12, 174–178 (1963).PubMedGoogle Scholar
  332. Shah, S., Pomeroy, V., Michaels, G., Coelho, M., Kinsell, L. W.: Glyceride and fatty acid response to fat loading in normal and abnormal subjects. Metabolism 12, 887–898 (1963).PubMedGoogle Scholar
  333. Shipp, J. C., Opie, L. H., Challoner, D.: Fatty acid and glucose metabolism in the perfused heart. Nature (Lond.) 189, 1018–1019 (1961).Google Scholar
  334. Smith, L. H. Jr., Ettinger, R. H., Seligson, D.: A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. J. clin. Invest. 32, 273–282(1953).PubMedGoogle Scholar
  335. Smith, S. W., Weiss, S. B., Kennedy, E. P.: The enzymatic dephosphorylation of phosphatidc acids. J. biol. Chem. 228, 915–922 (1957).PubMedGoogle Scholar
  336. Speck, L.: Arch. Ver. wiss. Heilk. 1, 232 (1865).Google Scholar
  337. Zit.nach Thannhauser, S. J.: Lipidoses: Diseases of the Intracellular Lipid Metabolism. 2nd Ed., p. 291. Oxford: Oxford Med. Publ. 1950.Google Scholar
  338. Spitzer, J. J., Bond, B. D., Grunwald, E. R.: Influence of protamine on alimentary lipemia. Amer. J. Physiol. 174, 43–45 (1953).PubMedGoogle Scholar
  339. Stein, Y., Shapiro, B.: The synthesis of neutral glycerides by fractions of rat liver homo-genates. Biochim. biophys. Acta (Amst.) 24, 197–198 (1957).Google Scholar
  340. Stein, Y., Shapiro, B.: Assimilation and dissimilation of fatty acids by the rat liver. Amer. J. Physiol. 196, 1238–1241 (1959).PubMedGoogle Scholar
  341. Stein, Y., Shapiro, B.: Uptake and metabolism of triglycerides by the rat liver. J. Lipid Res. 1, 326–331 (1960).PubMedGoogle Scholar
  342. Steinberg, D., Vaughan, M., Margolis, S., Price, H., Pittman, R.: Studies of triglyceride biosynthesis in homogenates of adipose tissue. J. biol. Chem. 236, 1631–1637 (1961).Google Scholar
  343. Steiner, G.: Lipoprotein lipase in fat-induced hyperlipemia. New Engl. J. Med. 279, 70–74 (1968).PubMedGoogle Scholar
  344. Stern, C. A., Iacono, J. M., Mueller, J. F.: Lipoprotein lipase in human adipose tissue. Proc. Soc. exp. Biol. (N. Y.) 110, 366–368 (1962).Google Scholar
  345. Swahn, B.: Studies on blood lipids. Scand. J. clin. Lab. Invest. 5, Suppl. 9 (1953).Google Scholar
  346. Swan, D. C., Davidson, P., Albrink, M. J.: Effect of simple and complex carbohydrates on plasma non-esterified fatty acids, plasma-sugar and plasma-insulin during oral carbohydrate tolerance tests. Lancet 1966I, 60–63.Google Scholar
  347. Thannhauser, S. J.: Lipidoses: Diseases of the Intracellular Lipid Metabolism, 2nd Ed. Oxford: Oxford Med. Publ. 1950.Google Scholar
  348. Tidwell, H. C., Johnston, J. M.: An in vitro study of glyceride absorption. Arch. Biochem. 89, 79–82 (1960).Google Scholar
  349. Tietz, A., Shapiro, B.: The synthesis of glycerides in liver homogenates. Biochim. biophys. Acta (Amst.) 19, 374–375 (1956).Google Scholar
  350. Tzur, R., Tal, E., Shapiro, B.: a-Glycerophosphate as regulatory factor in fatty acid esterification. Biochim. biophys. Acta (Amst.) 84, 18–23 (1964).Google Scholar
  351. Vaughan, M., Berger, J. E., Steinberg, D.: Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. J. biol. Chem. 239, 401–409 (1964).PubMedGoogle Scholar
  352. Volk, M. E., Millington, R. H., Weinhouse, S.: Oxidation of endogenous fatty acids of rat tissues in vitro. J. biol. Chem. 195, 493–501 (1952).PubMedGoogle Scholar
  353. Waddell, W. R., Geyer, R. P.: Effect of insulin on clearance of emulsified fat from the blood in depancreatized dogs. Proc. Soc. exp. Biol. (N. Y.) 96, 251–255 (1957).Google Scholar
  354. Waddell, W. R., Geyer, R. P., Hurley, N., Stare, F. J.: Abnormal carbohydrate metabolism in patients with hypercholesterolemia and hyperlipemia. Metabolism 7, 707–716 (1958).PubMedGoogle Scholar
  355. Waddell, W. R., Geyer, R. P., Saslaw, I. M., Stare, F. J.: Normal disappearance curve of emulsified fat from the blood stream and some factors which influence it. Amer. J. Physiol. 174, 39–42 (1953).PubMedGoogle Scholar
  356. Wadström, L. B.: Lipolytic effect of the injection of adrenaline on fat depots. Nature (Lond.) 179, 259–260 (1957).Google Scholar
  357. Wahl, P., Kettnaker, W.: The influence of β-receptor blocking agents on the behaviour of glucose and free fatty acids in tolbutamide and intravenous glucose tolerance tests in healthy subjects and in diabetics. Diabetologia 2, 225 (1966).Google Scholar
  358. Wakil, S. J., McLain, L. W., Jr., Warshaw, J. B.: Synthesis of fatty acids by mitochondria. J. biol. Chem. 235, PC 31–32 (1960).Google Scholar
  359. Weiss, S. B., Kennedy, E. P.: The enzymatic synthesis of triglycerides. J. Amer. Chem. Soc. 78, 3550–3561 (1956).Google Scholar
  360. Weiss, S. B., Kennedy, E. P., Kiyasu, J. Y.: The enzymatic synthesis of triglycerides. J. biol. Chem. 235, 40–44 (1960).PubMedGoogle Scholar
  361. Wenke, M., Mühlbachova, E., Škrobal, D.: Concerning the stress hypothesis of the hyperlipemic effect of protamine sulphate. Physiol. Bohemoslov. 9, 61–65 (1960).Google Scholar
  362. Wenner, C. E., Weinhouse, S.: An isotope tracer study of glucose catabolism pathways in liver. J. biol. Chem. 219, 691–704 (1956).PubMedGoogle Scholar
  363. White, J. E., Engel, F. L.: A lipolytic action of epinephrine and norepinephrine on rat adipose tissue in vitro. Proc. Soc. exp. Biol. (N. Y.) 99, 375–378 (1958).Google Scholar
  364. Whyte, M., Karmen, A., Goodman, D. S.: Fatty acid esterification and chylomicron formation during fat absorption. 2. Phospholipids. J. Lipid Res. 4, 322–329 (1963).PubMedGoogle Scholar
  365. Wieland, O., Suyter, M.: Glycerokinase: Isolierung und Eigenschaften des Enzyms. Biochem. Z. 329, 320–331 (1957).PubMedGoogle Scholar
  366. Wijnhausen,O. J.: Über Xanthomatose in einem Falle von recidivierender Pankreatitis. Berl. klin. Wschr. 58, 1268–1270 (1921).Google Scholar
  367. Windmueller, H. G., Levy, R. I.: Production of β-lipoprotein by intestine in the rat. J. biol. Chem. 243, 4878–4884 (1968).PubMedGoogle Scholar
  368. Wise, F., Garb, J.: Xanthoma diabeticorum with unusual form of eruption. Arch. Derm. Syph. (Chic.) 45, 723–733 (1942).Google Scholar
  369. Zakim, D., Pardini, R. S., Herman, R. H., Sauberlich, H. E.: Mechanism for the differential effects of high carbohydrate diets on lipogenesis in rat liver. Biochim. biophys. Acta (Amst.) 144, 242–251 (1967 a).Google Scholar
  370. Zaim, D., Pardini, R. S., Herman, R. H., Sauberlich, H. E.: The relation of hepatic α-glycerophosphate concentration to lipogenesis in rat liver. Biochim. biophys. Acta (Amst.) 137, 179–180 (1967b).Google Scholar
  371. Zemplènyi, T., Grafnetter, D.: Vliv hladovění a heparinu na lipolytickou aktivitu tkání. Cas. Lék. čes. 98, 97–101 (1959).Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1971

Authors and Affiliations

  • F. Sandhofer
    • 1
  • S. Sailer
    • 1
  • H. Braunsteiner
    • 1
  1. 1.Medizinischen UniversitätsklinikInnsbruckAustria

Personalised recommendations